MedTrace Logo

A Study of HR071603(Ketamine Nasal Spray) in Healthy Subjects

NCT04108234 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-06-16

No results posted yet for this study

Summary

The study is being conducted to evaluate the safety and pharmacokinetics of HR071603 in healthy subjects.

Conditions

Interventions

DRUG

HR071603

HR071603 monotherapy ,nasal spray

DRUG

placebo

placebo,nasal spray

Sponsors & Collaborators

  • Jiangsu HengRui Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-24
Primary Completion
2021-06-01
Completion
2021-06-01

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04108234 on ClinicalTrials.gov